
Inovio Pharmaceuticals
North America, Pennsylvania, United States, Plymouth Meeting
Description
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Investor Profile
Inovio Pharmaceuticals has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Oncology.
Stage Focus
- Series A (100%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Oncology
- Pharmaceutical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.